Abstract
Efficacy of weekly paclitaxel-bevacizumab combination in advanced non squamous non-small cell lung cancer (NSCLC) progressing after immune checkpoint inhibitors - AVATAX , a retrospective multicentric study: Preliminary data
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have